Comparative efficacy and safety analysis of CSE-1034: An open labeled phase III study in community acquired pneumonia

Comparative efficacy and safety analysis of CSE-1034: An open labeled phase III study in community acquired pneumonia

Objective: CSE-1034 is a novel antibiotic adjuvant entity (AAE) with proven activity against broad range of multi-drug resistant (MDR) pathogens causing various bacterial infections. This phase 3 clinical trial was designed to evaluate the efficacy and safety of CSE-1034 therapy for the treatment of...

Full description

Bibliographic Details
Main Authors:	Manu Chaudhary, Shiekh G. Ayub, Mohd A. Mir
Format:	Article
Language:	English
Published:	Elsevier 2018-09-01
Series:	Journal of Infection and Public Health
Online Access:	http://www.sciencedirect.com/science/article/pii/S187603411830042X

Similar Items

Post-marketing Safety and Efficacy Evaluation of a Novel Drug CSE-1034: A Drug-use Analysis in Paediatric Patients with Hospital-acquired Pneumonia
by: Manu Chaudhary, et al.
Published: (2018-09-01)

CSE-1034 versus ceftriaxone: Efficacy and safety analysis from a randomized, open-labeled phase III study in complicated urinary tract infections
by: Manu Chaudhary, et al.
Published: (2018-01-01)

Safety and efficacy of a novel drug elores (ceftriaxone + sulbactam + disodium edetate) in the management of multi-drug resistant bacterial infections in tertiary care centers: a post-marketing surveillance study
by: Manu Chaudhary, et al.
Published: (2017-07-01)

Waging War Against Extended Spectrum Beta Lactamase and Metallobetalactamase Producing Pathogens- Novel Adjuvant Antimicrobial Agent Cse1034- An Extended Hope
by: Manisa Sahu, et al.
Published: (2014-06-01)

Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study
by: Dunbar Lala M, et al.
Published: (2005-05-01)

Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia
by: Zhao B, et al.
Published: (2020-07-01)

An open label, multicenter, non-comparative study of the efficacy and safety of oral gatifloxacin in the treatment of community-acquired pneumonia: a Brazilian study in five centers
by: Antonio Carlos Nicodemo

An open label, multicenter, non-comparative study of the efficacy and safety of oral gatifloxacin in the treatment of community-acquired pneumonia: a Brazilian study in five centers
by: Nicodemo Antonio Carlos
Published: (2003-01-01)

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
by: Zolubas Marius, et al.
Published: (2009-09-01)

Software Engineering for CSE
by: Jeffrey C. Carver, et al.
Published: (2015-01-01)

J.S.Bach Flute Sonata BWV 1034 in e minor Analysis and Interpretation
by: Lin, Tz-Lin, et al.
Published: (2011)

An Analysis of GCE and CSE Examination Grades
by: Willmott, A. S.
Published: (1975)

Efficacy of immunovenin in patients with community-acquired pneumonia
by: Usman Raul'evich Farkhutdinov, et al.
Published: (2011-03-01)

EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY
by: I. V. Shirinsky, et al.
Published: (2014-07-01)

Integrated safety summary of phase II and III studies comparing oral nemonoxacin and levofloxacin in community-acquired pneumonia
by: Shih-Lung Cheng, et al.
Published: (2019-10-01)

The measurement of affective behaviour in C.S.E. mathematics
by: Preston, Michael
Published: (1972)

CSE: Complex-Valued System With Evolutionary Algorithm
by: Bin Yang, et al.
Published: (2019-01-01)

Best practices and future trends in CSE education
by: Sarkar, NI
Published: (2013)

Efficacy and safety of 1% forskolin eye drops in open angle glaucoma – An open label study
by: Muhammed Majeed, et al.
Published: (2015-07-01)

Homocysteine Triggers Inflammatory Responses in Macrophages through Inhibiting CSE-H2S Signaling via DNA Hypermethylation of CSE Promoter
by: Jiao-Jiao Li, et al.
Published: (2015-06-01)

Efficacy and safety of degarelix in Korean patients with prostate cancer requiring androgen deprivation therapy: Open-label multicenter phase III study
by: Dalsan You, et al.
Published: (2015-03-01)

The building of a centromeric nucleosome: Biochemical analysis and comparison of Cse4p, histone H3 and Cse4-286p to define the unique assembly pathway of a Cse4p nucleosome
by: Newell, Kelcy J
Published: (2006)

Comparative efficacy and safety of escitalopram versus desvenlafaxine in postmenopausal women with depression and anxiety: A randomized, open-label, comparative trial
by: Sonia Shinde Mahajan, et al.
Published: (2019-01-01)

Study on J.S. Bach sonatas for Flute and Basso Continuo—BWV1033､BWV1034､BWV1035
by: Hsiang-Wen Chou, et al.
Published: (2007)

Safety and efficacy of nemonoxacin versus levofloxacin in the treatment of community-acquired pneumonia: results of phase III, multicenter, randomized, double-blind, active-controlled, non-inferiority trial
by: Kozlov R.S., et al.
Published: (2018-11-01)

Safety and efficacy of duloxetine in Japanese patients with chronic knee pain due to osteoarthritis: an open-label, long-term, Phase III extension study
by: Uchio Y, et al.
Published: (2018-07-01)

Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study
by: Yu Q, et al.
Published: (2018-06-01)

Utilization of computer simulated experiments (CSE) for diagnostic purposes/
by: Thomson, Barbara Swanson,1934-
Published: (1971)

CSE-DT Features Selection Technique for Diabetes Classification
by: Matthew T. Ogedengbe, et al.
Published: (2020-03-01)

COMPUTER SELF EFFICACY (CSE) MAHASISWA AKUNTANSI DALAM PENGGUNAAN TEKNOLOGI INFORMASI: TINJAUAN PERSPEKTIF GENDER
by: Rustiana Rustiana
Published: (2004-01-01)

The objectives and implementation of practical studies in CSE geography : with particular reference to the 'Geography for the young school leaver' CSE work at a typical comprehensive school
by: John, R. O.
Published: (1980)

Efficacy and safety of escitalopram versus desvenlafaxine in the treatment of major depression: A preliminary 1-year prospective randomized open label comparative trial
by: Brij Mohan Gupta, et al.
Published: (2016-01-01)

Theta burst stimulation in adolescent depression: An open-label evaluation of safety, tolerability, and efficacy
by: Siddhesh Sanjeev Shere, et al.
Published: (2021-07-01)

Efficacy and safety of external trigeminal neurostimulation in the prevention of chronic migraine: An open-label trial
by: Marius Birlea, et al.
Published: (2019-06-01)

The efficacy and safety of infliximab in patients with ankylosing spondylitis: results of an open-labeled multicenter study
by: Nikolay Vasil'evich Bunchuk, et al.
Published: (2010-10-01)

An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
by: Pandina Gahan, et al.
Published: (2012-06-01)

Efficacy and Safety of Aripiprazole for Treatment of Irritability in Children with Autistic Disorder: An Open-Label Study
by: Nastaran Habibi, et al.
Published: (2015-11-01)

ABIFLOX EFFICACY IN COMPLEX THERAPY OF PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
by: T. I. Lyadova, et al.
Published: (2013-12-01)

The discovery of PSR J1833-1034: the pulsar associated with the supernova remnant G21.5-0.9
by: Gupta, Yashwant, et al.
Published: (2005)

Efficacy and Safety of Ceftaroline for the Treatment of Community-Acquired Pneumonia: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
by: Shao-Huan Lan, et al.
Published: (2019-06-01)

Cannot write session to /tmp/vufind_sessions/sess_vjfeo8crvge1qlgjf74o1objks